# Alpha-1-acid Glycoprotein as a Biomarker of Developmental Diagnosing and Monitoring Effectiveness in Sepsis

> **NCT01838525** · — · UNKNOWN · sponsor: **Chinese PLA General Hospital** · enrollment: 1 (estimated)

## Conditions studied

- Systemic Inflammatory Response Syndrome
- Sepsis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01838525
- **Lead sponsor:** Chinese PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-04
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2013-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01838525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01838525, "Alpha-1-acid Glycoprotein as a Biomarker of Developmental Diagnosing and Monitoring Effectiveness in Sepsis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01838525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*